Martin Lipp
4Patents
1h-index
10Co-inventors
45Inventor score
Filing activity: Aug 13, 1996 → Jul 8, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10189906B2 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Chemistry; Metallurgy | 6 | Active |
| US6232123A | Monoclonal antibodies against leucocyte-specific G protein-coupled receptors | Emerging Cross-Sectional Technologies | 0 | Expired |
| US10745486B2 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US11667722B2 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.